Equillium, Inc. (EQ) vs ImmuCell Corporation (ICCC)
A side-by-side comparison of Equillium, Inc. and ImmuCell Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EQ
Equillium, Inc.
$1.44HealthcareDelayed quote: Oct 6, 2026, 12:39 PM EDT
ICCC
ImmuCell Corporation
$10.00HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — EQ vs ICCC
growth of $100 · dividends reinvested · last 8yEQ -89.6% (-24.7%/yr)ICCC +18.2% (+2.1%/yr)ICCC compounded faster over this window
Log scale — wide-divergence pair
EQ ICCC
EQ vs ICCC: by the numbers
- •EQ is the larger company ($91M vs $90M market cap).
- •ICCC is profitable (2.57% net margin) while EQ runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | EQ | ICCC |
|---|---|---|
| P/E ratio | N/A | 118.20 |
| P/S ratio | N/A | 2.95 |
| P/B ratio | 1.62 | 2.88 |
| EV / EBITDA | N/A | 15.05 |
| FCF yield | N/A | 4.66% |
Profitability
| Metric | EQ | ICCC |
|---|---|---|
| Gross margin | 0.00% | 40.32% |
| Operating margin | 0.00% | 12.60% |
| Net margin | 0.00% | 2.57% |
| ROE | -32.15% | 2.51% |
| ROIC | -34.10% | 8.16% |
Growth (annualized)
| Metric | EQ | ICCC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.74% |
| Total return CAGR (5Y) | -26.99% | 0.65% |
Frequently asked
- Is EQ or ICCC more profitable?
- ICCC runs the higher net margin — EQ at 0.00% versus ICCC at 2.57%.
- How have EQ and ICCC total returns compared?
- Over the past 5 years, EQ delivered -26.99% and ICCC delivered 0.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ImmuCell P/E ratioEquillium ROEImmuCell ROEEquillium operating marginImmuCell operating marginEquillium revenue growthImmuCell revenue growthEquillium free cash flowImmuCell free cash flow
Equillium & ImmuCell appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.